Apotex recently announced a recall for the popular diabetes drug, metformin, because the drug may contain possible high levels of N-Nitrosodimethylamine (NDMA).
Earlier this week, a recall was issued for the popular diabetes drug, metformin. The recall was announced by Apotex and was issued because the drug may contain “possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people.” The recall specifically includes “all lots of metformin hydrochloride extended-release tablets 500 mg.” The issued was found by the U.S. Food and Drug Administration (FDA) during routine testing discovered “higher NDMA levels than allowed” in one lot of the product.
For those who don’t know, NDMA is an environmental contaminant most commonly found in food and water, such as dairy products, vegetables, and meat products. However, “NDMA contamination triggered numerous recalls of widely-used heart medicines last year.” Metformin hydrochloride extended-release tablets are often prescribed to patients as a supplement to diet and exercise “to improve blood sugar control in adults and children age 10 and older with type 2 diabetes.”
“Patients should continue taking metformin tablets even after recalls occur until they consult with their health care professional who can prescribe a replacement. Patients with type 2 diabetes could face dangerous health risks if they stop taking their prescribed metformin.”